Advocacy

AHPA advocates the U.S. Congress; state governments; FDA; FTC; USDA; FWS; NIH; NCCIH; U.S. Pharmacopeia and others for effective laws and regulations that promote the responsible commerce of herbal products.

News

AHPA informs members and the industry about news and issues through daily email alerts and a monthly newsletter. AHPA also promotes the benefits of herbs to mainstream and industry media as well as scientific journals.

Events

AHPA regularly produces in-person and online educational events featuring industry-leading experts discussing regulatory and technical issues that impact the herbal product industry. 

Resource Library

AHPA provides Guidance Documents, Policies, Trade Requirement, and Reference Materials to help members comply with the herbal industry laws and regulations.

Latest News

  • Blog Article Image

    December 9, 2022 The American Herbal Products Association (AHPA) is issuing its annual call for candidates for elected trustees to the association's Board of Trustees. AHPA's bylaws and election policies govern this nomination process and election.   "AHPA's trustees provide invaluable experience and expertise to our staff and membership, and we are grateful for their leadership and contributions to the association," said AHPA President Michael McGuffin. "We encourage all eligible companies to nominate a representative for this opportunity to help shape the future of this industry."   About the Board The number of seats on AHPA's Board of Trustees consists of a minimum of 22. Two elected seats are reserved for "small business members," defined as Active Members with $5 million or less in annual herbal revenues. The remaining elected seats are available to all Active Members in good standing. The term of office for all elected trustees is three years.   AHPA's Board of Trustees meets three times each year (including in-person meetings at the Natural Products Expo West and SupplySide West trade shows), and trustees are expected to attend all meetings. In addition, trustees are expected to participate in ongoing functions of the organization. While trustees receive no remuneration for their services, the benefits to the companies represented, and to the industry as a whole, are well recognized.   Nomination & Election   A candidate must be officially nominated in writing by submitting a completed Intent to Stand for Election Form and Candidate's Statement by no later than Friday, February 3, 2023.   A candidate for AHPA's Board of Trustees may be an owner, employee, consultant, or other designated representative of the company wishing to be represented on the board. All Active Members in good standing are qualified and encouraged to nominate a candidate.   The election for the 2023 cycle will be held in a virtual format during AHPA's Annual Member Meeting on Wednesday, March 8, 2023 at Natural Products Expo West in Anaheim, Calif. Candidates will be asked to record a short video address in advance for the membership that will be played during the meeting before voting closes. For any questions about the election process, please contact Melissa Do, AHPA Director of Communications, at mdo@ahpa.org.

    • Friday, December 9, 2022
    • | Posted by AHPA
  • Blog Article Image

    December 8, 2022 Yesterday, U.S. Senate Majority Whip Dick Durbin (D-IL) delivered a speech on the Senate floor seeking support from his colleagues to include mandatory product listing (MPL) provisions from his Dietary Supplement Listing Act (DSLA) in the end-of-year omnibus appropriations bill. The MPL provisions from the DSLA, which Durbin introduced with U.S. Senator Mike Braun (R-IN) in April, would amend the Food Drug and Cosmetic Act (FD&CA) to require marketers of dietary supplements sold in the United States to list their products with the U.S. Food and Drug Administration (FDA). Durbin's bid to include MPL provisions in the omnibus bill comes as the current continuing resolution funding the federal government is set to expire on December 16. Last week, in a letter sent to the leadership of the Senate and House of Representatives committees with oversight over FDA, the American Herbal Products Association (AHPA) requested that Congress not include MPL language in any must-pass appropriations legislation considered during the last weeks of the 117th Congress. AHPA also suggested that any discussion of changes to federal laws regulating dietary supplements should occur as part of a transparent and stakeholder-inclusive process in the 118th Congress that will convene in January 2023. AHPA will continue to advocate for commonsense reforms to dietary supplement laws, including greater consumer access to truthful information about dietary supplements and a more equitable and transparent path to market for new dietary ingredients.

    • Thursday, December 8, 2022
    • | Posted by AHPA
  • Blog Article Image

    December 6, 2022 AHPA is pleased to support the upcoming Americans for Safe Access (ASA) National Medical Cannabis Unity Conference as a Host Committee Sponsor. The annual event recently moved to a virtual format and will focus on highlighting past accomplishments, discussing current issues that remain, and looking forward to a future in which patients, no matter where they live or what condition they have, will have access to safe and affordable cannabis-based therapeutics. ASA was founded in 2002 to give voice to the needs of medical cannabis patients. Over the last 20 years, ASA has brought together patients, policy experts, public health experts, attorneys, lobbyists, scientists, industry associations, and medical professionals to create the campaigns, projects, and programs that have broken down political, social, academic, and legal barriers across the world.

    • Tuesday, December 6, 2022
    • | Posted by AHPA
  • Blog Article Image

    December 1, 2022 In a letter to the leadership of the Senate and House of Representatives committees with oversight for the U.S. Food and Drug Administration (FDA), the American Herbal Products Association (AHPA) has requested that Congress not include mandatory product listing (MPL) language in any must-pass appropriations legislation considered during the last weeks of the current 117th Congress. MPL as presented by its advocates would amend the Food Drug and Cosmetic Act (FD&CA) to require dietary supplement firms to list their products with the Food and Drug Administration (FDA), a proposal that has been the subject of significant controversy during the current Congress.   AHPA's letter also cited a long history of regular order amendments to the FD&CA's provisions impacting dietary supplements. In addition, the letter suggested that any discussion of changes to federal laws regulating dietary supplements should occur as part of a transparent and stakeholder-inclusive process in the 118th Congress that will convene in January 2023.   “There are areas of the law governing dietary supplements that may benefit from a thoughtful review to ensure that Americans have ready and informed access to a wide range of safe dietary supplements,” said AHPA President Michael McGuffin. “Any statutory changes that are identified as needed to achieve this purpose should then be considered as a package, rather than with a sole focus on MPL, and the resulting legislative process should allow public involvement and discussion.”   AHPA will continue to advocate for commonsense reforms to dietary supplement laws, including greater consumer access to truthful information about dietary supplements and a more-equitable and transparent path to market for new dietary ingredients.

    • Thursday, December 1, 2022
    • | Posted by AHPA
View All News >

Events

View Calendar >
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services.
AHPA has no responsibility for any transaction entered into with any of these companies.